ArticleClinical medicine insights. Endocrinology and diabetes2011

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.

Jay Shubrook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.